The metabolomics market for CROs is estimated to be worth $173 million and is expected to grow at compounded annual growth rate (CAGR) of 14.9% during the forecast period. The report turns the spotlight on the major challenges faced by the key players in the global market and the growth strategies currently adopted by them. The report is a granular assessment of this particular business sphere...
Digital biomanufacturing harnesses various advancements, such as real-time monitoring, data analytics, automation, modelling, process optimization and other digital tools to transform the available information into actionable insights.
The global digital manufacturing market size is anticipated to reach at USD 2.0 billion in 2024 to 12.30 billion by 2035, to grow at a compounded annual growth...
The liquid biopsy market is expected to grow from USD 8.20 billion in 2025 to USD 9.49 billion in 2026 and USD 33.45 billion by 2035, at a CAGR of 15.0% from 2024 to 2035. The report will help readers stay updated with the latest market trends and maintain their competitive outlooks in the modern-day fast-paced business environment. The report comes with a concise summary of the details...
The Global Medical polymers market size is expected to grow from USD 20.8 billion in 2024 to USD 22.1 billion in 2025 and USD 46.0 billion by 2035, at a CAGR of 7.6% during the forecast period till 2035. The report turns the spotlight on the major challenges faced by the key players in the global market and the growth strategies currently adopted by them. The report is a granular assessment of...
The pharmacy market size is expected to grow from USD 2.5 trillion in 2025 to USD 2.6 trillion in 2026 and USD 4.1 trillion by 2035, growing at a CAGR of 5%, during the forecast period, till 2035.
In the market study report, our authors extensively covered qualitative and quantitative analysis including investment opportunities to help stakeholders in evaluating the major growth drivers and...
Respiratory syncytial virus infections are recognized among the prevalent respiratory diseases, accounting for approximately 33 million new cases in children aged under five years, annually. Currently, several traditional techniques are available for treating these infections, although none of them have been competent enough to reduce the healthcare burden of RSV diseases. In order to address...
SPARK Website
عربي
